Home - Products - Autophagy - CXCR - USL311

USL311

CAS No. 1373268-67-7

USL311( —— )

Catalog No. M22471 CAS No. 1373268-67-7

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	106	In Stock
5MG	178	In Stock
10MG	259	In Stock
25MG	434	In Stock
50MG	627	In Stock
100MG	893	In Stock
500MG	1782	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

USL311
Note

Research use only, not for human use.
Brief Description

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
Description

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Autophagy
Target

CXCR
Recptor

CXCR4
Research Area

Cancer
Indication

Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)

Chemical Information

CAS Number

1373268-67-7
Formula Weight

422.57
Molecular Formula

C24H34N6O
Purity

>98% (HPLC)
Solubility

DMSO:24 mg/mL (59.79 mM; Need ultrasonic)
SMILES

CC(C)N1CCC(CC1)N1CCCN(CC1)c1cccc(n1)C(=O)Nc1ccncc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Peter Richardson. Usl-311 for use in the treatment of cancer. WO2018162924A1

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CTCE 9908

CXCR4 antagonist; induces mitotic catastrophe in ovarian cancer cells. Displays additive cytotoxic effects when given with taxol. Enhances the efficacy of docetaxel in a mouse model.
CXCL-CXCR1/2-IN-1

CXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer.
AD80

AD80, a multikinase inhibitor, inhibits RET, RAF, SRCand S6K, with greatly reduced mTOR activity.

Sign In Join Free